Meeting Coverage > SABCS Skip Surgery for DCIS in Favor of Active Monitoring? — No invasive cancer increase at 2 years, but editorialists say data don't back active monitoring by Charles ...

These findings support current guidelines from the National Comprehensive Cancer Network, which advises that women who receive a lumpectomy for DCIS consider tamoxifen after surgery, researchers ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage ...

Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ.

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received ...

SAN ANTONIO — A large trial has begun to make the case for active surveillance as an alternative to immediate surgery for low-risk ductal carcinoma in situ (DCIS).

The finding is based on following more than 950 U.S. patients randomly assigned to surgery or active monitoring. All had low-risk DCIS with no sign of invasive cancer.

If more cancer is found during a lumpectomy, and all the patient has agreed to is a lumpectomy, the surgeon may try to increase the margins by taking more tissue from the edges that he or she ...

Diana Zuckerman, the group's president, defines DCIS as a noninvasive cancer that can usually be treated effectively with lumpectomy and radiation rather than mastectomy. (Published 10/21/04) ...